We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
AAF
401
Andra AP-fonden
Sweden
$23.6M -$1.74M -55,440 -7%
PA
402
Pinnacle Associates
New York
$23.6M +$446K +14,178 +2%
OSAM
403
O'Shaughnessy Asset Management
Connecticut
$23.1M +$1.56M +49,717 +7%
WT
404
Whittier Trust
California
$23.1M -$698K -22,198 -3%
MIFH
405
Migdal Insurance & Financial Holdings
Israel
$23M +$23.6M +751,489 New
GI
406
GAMCO Investors
Connecticut
$22.8M -$764K -24,293 -3%
SLAM
407
Swiss Life Asset Management
$22.5M +$1.2M +38,209 +5%
GIA
408
Guyasuta Investment Advisors
Pennsylvania
$22.4M -$226K -7,188 -1%
SC
409
Scotia Capital
Ontario, Canada
$22.4M +$688K +21,863 +3%
B
410
BP
United Kingdom
$22.3M -$6.76M -215,016 -23%
SI
411
Standard Investments
New York
$22.2M
CEI
412
Clark Estates Inc
New York
$22.2M -$1.41M -44,900 -6%
William Blair & Company
413
William Blair & Company
Illinois
$22.2M +$299K +9,515 +1%
UIC
414
Uniplan Investment Counsel
Wisconsin
$22M -$2.74M -87,106 -11%
WIM
415
Waverton Investment Management
United Kingdom
$21.9M -$766K -24,349 -3%
GL
416
GLG LLC
New York
$21.8M -$27.9M -888,382 -56%
NMERB
417
New Mexico Educational Retirement Board
New Mexico
$21.6M -$776K -24,664 -3%
BC
418
Blackhill Capital
New Jersey
$21.5M +$26.6K +844 +0.1%
TCT
419
TIAA CREF Trust
Missouri
$21.4M +$550K +17,473 +3%
Creative Planning
420
Creative Planning
Kansas
$21.3M +$2.97M +94,531 +16%
UB
421
UMB Bank
Missouri
$21.2M +$5.66M +180,062 +35%
CIP
422
Chartwell Investment Partners
Pennsylvania
$21.2M -$327K -10,396 -1%
WI
423
Wafra Inc
New York
$21.1M -$1.64M -52,037 -7%
FP
424
Foundry Partners
Minnesota
$20.9M +$21.5M +683,677 New
WAM
425
World Asset Management
Michigan
$20.8M +$964K +30,648 +5%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.